FDA Details Procedures to Approve Emergency Research Without Informed Consent

Drug Industry Daily
The FDA Monday issued new requirements for emergency research on incapacitated patients, stressing that sponsors must search for a patient’s family to seek permission to continue any trial started without consent and allow patients to opt out once they’re conscious.

To View This Article:


Subscribe To Drug Industry Daily